UPL Ltd (NSE:UPL)
₹ 510 -4.8 (-0.93%) Market Cap: 382.81 Bil Enterprise Value: 610.46 Bil PE Ratio: 0 PB Ratio: 1.38 GF Score: 82/100

UPL Ltd Capital Markets Day Transcript

May 17, 2019 / 10:30AM GMT
Release Date Price: ₹647.1 (-0.02%)
Anand Kantilal Vora
UPL Limited - CFO

Good afternoon. Good afternoon, ladies and gentlemen, and welcome to the UPL Capital Market Day.

Financial year '18-'19 has been a momentous year for UPL. As you all know, on 20th of July, we announced the acquisition of Arysta LifeScience for a total consideration of $4.2 billion. And in just 6.5 months, we have closed the transaction and started operating as one company effective 1st of February 2019. Besides this, this year, as some of you may know, is the 50th year of -- 50th year UPL has completed as the Golden Jubilee year. In today's Board meeting, the Board has approved issuance of bonus shares in the ratio of 1 share for every 2 shares held subject to the shareholders' approval.

With this, we move onto the agenda for the Capital Market Day. We start off with the presentation of Mr. Jai Shroff, followed by a presentation from Mr. Diego Casanello, who is our -- who was the CEO of Arysta LifeScience and is now the CEO (sic) [COO] of the combined entity. Followed by this presentation, you'll have a presentation from Carlos Pellicer, who -- I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot